Elevated levels of blood YKL-40 have been correlated with disease severity, such as in the advanced clinical stage of Hodgkin’s lymphoma [13], DLBCL [10], and cutaneous T-cell lymphoma [11,12]. Here, CHI3L1 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.